These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3775655)

  • 1. Enterobacter bacteremia in surgical patients.
    Burchard KW; Barrall DT; Reed M; Slotman GJ
    Surgery; 1986 Nov; 100(5):857-62. PubMed ID: 3775655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterobacter bacteremia in the community hospital.
    Haddy RI; Cecil ML; Norris LL; Markert RJ
    J Fam Pract; 1991 Jun; 32(6):601-6. PubMed ID: 2040885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterobacter bacteremia in pediatric patients.
    Gallagher PG
    Rev Infect Dis; 1990; 12(5):808-12. PubMed ID: 2237121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of critically ill patients with bacteremia].
    Du B; Chen D; Li H
    Zhonghua Yi Xue Za Zhi; 1998 Jun; 78(6):416-9. PubMed ID: 10923501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer.
    Huh K; Kang CI; Kim J; Cho SY; Ha YE; Joo EJ; Chung DR; Lee NY; Peck KR; Song JH
    Diagn Microbiol Infect Dis; 2014 Feb; 78(2):172-7. PubMed ID: 24321352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative nosocomial Enterobacter Sakazakii sepsis.
    Ray P; Das A; Gautam V; Jain N; Wig JD; Sharma M
    ANZ J Surg; 2007 Oct; 77(10):915-6. PubMed ID: 17803568
    [No Abstract]   [Full Text] [Related]  

  • 11. Enterobacter aerogenes primary bacteremia in pediatric patients.
    Edwards KE; Allen JR; Miller MJ; Yogev R; Hoffman PC; Klotz R; Marubio S; Burkholder E; Williams T; Davis AT
    Pediatrics; 1978 Sep; 62(3):304-6. PubMed ID: 704200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
    Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
    Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nosocomial bacteremia caused by Enterobacter spp.: epidemiology and prognostic factors].
    Peña C; Pujol M; Pallarés R; Cisnal M; Ariza J; Gudiol F
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):424-8. PubMed ID: 8260514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterobacter cloacae bacteremia in children: a review of 30 cases in 12 years.
    Bonadio WA; Margolis D; Tovar M
    Clin Pediatr (Phila); 1991 May; 30(5):310-3. PubMed ID: 2044341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital.
    Choi HK; Kim YK; Kim HY; Park JE; Uh Y
    Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of Enterobacter bacteremia in pediatric patients: a 10-year study.
    Chen HL; Lu JH; Wang HH; Chen SJ; Chen CJ; Wu KG; Tang RB
    J Microbiol Immunol Infect; 2014 Oct; 47(5):381-6. PubMed ID: 23773708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterobacter bacteremia.
    Gupta N; Aparna ; Choudhary U; Garg N; Arora DR
    J Assoc Physicians India; 2003 Jul; 51():669-72. PubMed ID: 14621034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
    O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
    Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterococcal bacteremia in surgical patients.
    Barrall DT; Kenney PR; Slotman GJ; Burchard KW
    Arch Surg; 1985 Jan; 120(1):57-63. PubMed ID: 3966874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.